Prophylactic platelet transfusion in patients with hematologic malignancy

Recently published in NEJM:

Conclusions

The results of our study support the need for the continued use of prophylaxis with platelet transfusion and show the benefit of such prophylaxis for reducing bleeding, as compared with no prophylaxis. A significant number of patients had bleeding despite prophylaxis.